Publications by authors named "Hefeng Geng"

Claim this Profile
D
Design, synthesis, and antitumor activity study of β-carboline derivatives as selective HDAC1/2 inhibitors.
Zhiya Wang, Limeng Wu, Kaisi Yang, Yiming Qi, Zhenshu Li, Hefeng Geng

Bioorg Chem· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect and mechanism of novel HDAC inhibitor ZDLT-1 in colorectal cancer by regulating apoptosis and inflammation.
Hefeng Geng, Fangyuan Zheng, Wentao Sun, Shuoqi Huang, Zhiya Wang

Int Immunopharmacol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy and safety of PI3K and AKT inhibitors for patients with cancer: A systematic review and network meta-analysis.
Yingshi Zhang, Xiangbo Xu, Kaisi Yang, Shuai Wang, Tianqi Zhang, Hefeng Geng

Eur J Pharmacol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of ZJCK-6-46: A Potent, Selective, and Orally Available Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A Inhibitor for the Treatment of Alzheimer's Disease.
Huanhua Chen, Xudong Gao, Xinzhu Li, Chong Yu, Wenwu Liu, Hefeng Geng

J Med Chem· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ADAM17 inhibitor ZLDI-8 sensitized hepatocellular carcinoma cells to sorafenib through Notch1-integrin β-talk.
Chang Xu, Xudong Gao, Tianshu Ren, Hefeng Geng, Kaisi Yang

Pharmacol Res· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Which is the best TACE agent for patients with different NLR hepatocellular carcinomas? A systematic review and network meta-analysis.
Shuai Wang, Hefeng Geng, Yizhen Li, Ziang Xu, Kaisi Yang

Heliyon· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of renal cell carcinoma after solid organ transplantation: a systematic review and meta-analysis.
Chang Xu, Hefeng Geng, Yannan Li, Fang Sun, Huiwei Sun

BMC Urol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What Is the Most Suitable Agent Combined With Apatinib for Transarterial Chemoembolization Treatment in Advanced Hepatocellular Carcinoma Patients? A Systematic Review and Network Meta-analysis.
Fuhai Hui, Chang Xu, Xiangbo Xu, Jiangxia Chen, Hefeng Geng

Front Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis